Issue No. 4 · Week of September 7, 2026
This week was less about any single rule than about resilience. Boston Scientific’s cyberattack kept rippling into hospital ordering two weeks on, and a run of FDA recalls, from spinal cord stimulator leads to convenience kit components, kept traceability front and center.
On the trade side, CBP starts voiding importer of record numbers over bad Form 5106 data on September 18, and Canada’s counter-tariffs took effect September 8 with devices still off the list, for now. If you sell into the U.S. or Canada, this is a good week to check your own Form 5106 record and keep watching that tariff list.
Hospitals and Health Systems
Vizient Raises Hospital Supply Cost Forecast to 2.78% as Tech-Enabled Products Outpace Estimates
Vizient revised its hospital supply expense inflation forecast upward from 2.41% to 2.78% for the year ending June 2027, saying its original estimate held for tangible goods but underestimated IT hardware, software and chip-enabled equipment.
Capital equipment and surgical supplies remain among the categories pushing costs higher. It is a useful data point for setting U.S. price expectations, since hospital supply chain leaders are now watching technology-enabled device categories as closely as pharmacy for cost growth.
Source: Becker’s Hospital Review – August 28, 2026
Hospital Supply Chain Leaders Detail Their Playbook for Vendor Cyberattacks After Boston Scientific Outage
More than a week after an August 25 cyberattack disrupted Boston Scientific’s order and shipment processing worldwide, hospital supply chain leaders described their standard response: assess inventory exposure, hold daily huddles with suppliers and clinical staff, and keep pre-vetted substitute products on hand before a disruption hits.
It is a direct look at how one manufacturer’s cybersecurity incident becomes a hospital operations problem, and a reminder that hospitals now expect vendors to treat supply chain resilience as part of patient care, not just IT.
Federal Health Systems: VA and DoD
VA Watchdog Finds Supply Chain Breakdowns Closed Operating Rooms Four Times at Augusta VA
A VA Office of Inspector General review of the Augusta, Georgia VA found inventory records mismatched physical counts for 89 of 100 sampled items, more than 50 pallets of expired or unusable supplies sitting in storage, and a $3.2 million inventory system purchased in 2021 but never fully put into use.
The failures contributed to four operating room closures between October 2025 and February 2026, one lasting 27 days. For any manufacturer selling into VA facilities, it is a concrete reminder that a national contract does not guarantee smooth local execution, and delivery and storage at individual sites deserve close attention.
Source: VA Office of Inspector General – September 2, 2026
House Passes Stopgap Bill Funding FDA and VA Operations Through December 11
The House passed a continuing resolution on a bipartisan 370-48 vote to keep the federal government, including the VA and FDA, funded through December 11, 2026, averting a near-term funding lapse. The bill still needs Senate action before current funding expires.
Continued funding matters directly to foreign manufacturers, since a lapse can slow FDA device reviews and inspections and disrupt VA purchasing and clinical operations.
Regulatory: FDA and Health Canada
Boston Scientific Spinal Cord Stimulator Leads Recalled as Class I After 1,081 Injury Reports
FDA classified as Class I a Boston Scientific recall of Infinion CX spinal cord stimulator leads after 1,081 serious injury reports tied to mechanical stress at the anchor site that can cause lead fractures or loss of pain control stimulation.
The recall covers only unused leads still in the field, and Boston Scientific is moving customers to a newer lead design. It is a reminder of how quickly a manufacturing tolerance issue can escalate into a Class I action with full CAPA and field correction obligations.
Source: MedTech Dive – September 4, 2026
Medline Convenience Kits Corrected Again Over BD ChloraPrep Sterile Barrier Defects
FDA posted a correction for Medline convenience kits containing BD ChloraPrep applicators after Becton Dickinson found wrinkled or incompletely sealed packaging that could break the sterile barrier, the second BD ChloraPrep-related correction to hit downstream kit assemblers in as many weeks.
Medline is directing hospitals to remove and discard the affected applicators rather than pulling entire kits. It is another reminder that a single supplier’s quality problem can trigger repeated corrective actions across other companies’ finished kits, and that component-level traceability matters even when you only supply part of what ends up in a hospital kit.
Source: FDA, Center for Devices and Radiological Health – September 2, 2026
Import, Customs and Trade
CBP to Start Voiding Importer of Record Numbers Over Inaccurate Form 5106 Data on September 18
Starting September 18, CBP will immediately void an importer of record number if the address, email or phone on file in Form 5106 does not belong directly to the importer, for example a customs broker’s address or a third-party email.
A voided IOR number halts cargo clearance at the border with no advance warning. Any foreign device manufacturer relying on a broker or agent as importer of record should pull and verify its current Form 5106 record now, before the deadline.
Source: Clark Hill Client Alert – August 26, 2026
Canada’s Dollar-for-Dollar Counter-Tariffs on U.S. Goods Take Effect September 8
Canada’s retaliatory tariffs on roughly $27.6 billion of U.S. goods, including steel, dairy, appliances and electronics, took effect September 8 at 12:01 a.m., matching U.S. Section 338 tariffs dollar for dollar.
The Canada Border Services Agency confirmed formal implementation guidance would not be published until just before the deadline, leaving importers little time to prepare. No medical devices currently appear on the published list, but both governments have added categories with little notice before, so it is worth tracking closely.
Also Noted
Boston Scientific Cardiac Monitor Software Recall
Boston Scientific’s LUX-Dx cardiac monitors and LATITUDE Clarity software drew a Class II recall after atrial fibrillation alerts could be delayed under a non-default clinic setting, a reminder that server-side software falls within recall obligations too.
Source: Cardiovascular Business
Medline Recalls Neonatal and Infant Heated Wire Breathing Circuits
Medline issued a nationwide Class II recall of more than 17 Hudson RCI neonatal and infant heated wire breathing circuit models after reports the heater connector can discolor, melt or smoke.
House Veterans Affairs Committee Moves to Subpoena Oracle Executives
The House Veterans Affairs Committee voted to subpoena Oracle’s top executives after the company skipped a hearing on the VA’s electronic health record project, whose contract ceiling has grown to roughly $27 billion.
Source: Healthcare Dive
Pennsylvania Clears WVU Medicine’s Five-Hospital Acquisition
Pennsylvania cleared WVU Medicine’s roughly $800 million acquisition of five Independence Health System hospitals, with conditions requiring WVU to maintain services for five years, a sign vendor contract integration there will move slowly.
Source: Becker’s Hospital Review
Key Takeaways for Medical Device Manufacturers
This week’s developments reinforce three priorities for manufacturers selling into the U.S. and Canadian markets: maintain component-level traceability throughout the supply chain, treat cybersecurity and continuity planning as part of customer and patient-care obligations, and verify importer information before regulatory or customs enforcement creates a shipment disruption.
Manufacturers importing into the United States should pay particular attention to the September 18 CBP Form 5106 enforcement date, while companies trading with Canada should continue monitoring changes to the country’s counter-tariff list.
Questions About U.S. or Canadian Market Access?
Dawa Medical supports foreign medical device manufacturers entering the U.S. market as U.S. Agent, FDA Initial Importer and Importer of Record, with 3PL warehousing and regulatory compliance support. Through TB Medical Inc., manufacturers can also access Canadian importation and distribution support.
About The Access Brief: The Access Brief summarizes publicly reported news affecting medical device manufacturers selling into the United States and Canada and reflects Dawa Medical’s own understanding. It is not legal, regulatory or binding advice, and formal advice should come from qualified counsel or a specialist consultant.
